Skip to content

Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis C2717865

Published: July 22, 2026Updated: August 20, 2026

A group of autoimmune disorders causing blood vessel inflammation. It primarily affects adults and can damage organs. Treatment typically involves immunosuppressive medications and corticosteroids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Mononeuritis multiplex

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hematuria

(urinary)

Weight loss

(systemic)

Sinusitis

(ENT)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Induction immunosuppression

Combination therapy with high-dose corticosteroids and either rituximab or cyclophosphamide to rapidly suppress ANCA-mediated vasculitic inflammation and prevent organ damage.

medication
3

Plasma exchange

Removal of circulating ANCA antibodies and inflammatory mediators, particularly indicated for severe renal involvement or pulmonary hemorrhage in active vasculitis.

procedure

Additional treatment options

Maintenance immunosuppression

Long-term lower-dose immunosuppression with agents such as azathioprine, methotrexate, or rituximab to maintain remission and prevent disease flares.

medication

Organ-specific surveillance

Regular monitoring of renal function, lung imaging, and ANCA titers to detect organ involvement and early signs of disease relapse requiring treatment adjustment.

monitoring

Cardiovascular risk reduction

Lifestyle modifications including smoking cessation, regular exercise, and blood pressure management to reduce increased cardiovascular risk associated with vasculitis and its treatments.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis C2717865?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Suppiah R, Robson JC, Luqmani RA. EUVAS consensus guidelines for ANCA-associated vasculitis. Rheumatology. 2021.

guideline2021
2

Kitching AR, Anders HJ, Basu N. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020.

review2020
3

Stone JH, Merkel PA, Spiera R. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010.

clinical_trial2010
4

Park J, Chang HS, Park SY. Avacopan for ANCA-associated vasculitis: a systematic review and meta-analysis. Kidney Int. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis C2717865. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy